FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments
NEWS & BLOGS
FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development
OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings
FDA approves drug for adults with rare form of bone marrow disorder
FDA updates Sotrovimab emergency use authorization
FDA authorizes revisions to Evusheld dosing
FDA Approves Treatment for Wider Range of Patients with Heart Failure
FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
FDA Approves First Generic of Restasis
FDA, Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age
FDA Takes Key Action by Approving Second COVID-19 Vaccine
FDA Safety Warning, Stop Using Empowered Diagnostics COVID-19 Tests
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19
FDA warns about dental problems with buprenorphine medicines
FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five MonthsShareTweetLinked
FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19
Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S Market by Biden-Harris Administration
FDA Urges Manufacturers to Develop Solutions for iPLEDGE REMS Website
FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations